Navigation Links
Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Society's Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
Date:11/4/2008

JERUSALEM, November 4 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of proprietary drug delivery systems, announced today that its poster entitled "Enteral Administration of Exenatide-4; Proof of Concept Pharmacodynamic Study in Dogs," has been accepted for presentation at the Diabetes Technology Society's Eighth Annual Meeting in Bethesda, Maryland between November 13-15, 2008.

Oramed's exploratory study of enteral delivery of GLP-1 analog, exenatide-4, an incretin mimetic with antihyperglycemic actions on dogs, advances research in the area of enteral delivery of polypeptides and proteins. Oramed's test results showed that direct instillation of GLP-1 analog significantly curbed post-glucose loading, demonstrating the feasibility of administering the drug enterally.

"The selection of Oramed as one of the companies to present at the Diabetes Technology Conference is a wonderful opportunity for us to demonstrate our revolutionary technology to the world's leading diabetes scientists," said Nadav Kidron, Oramed CEO. "We are very proud that our research is advancing the treatment of diabetes and we look forward to continuing to present strong results from the studies and trials we are currently conducting."

Oramed's abstract will be presented on Thursday, November 13, from 6-8 PM. The poster will be available for viewing throughout the conference.

For more information about the Diabetes Technology Society's Eighth Annual Meeting, please visit http://www.diabetestechnology.org/index.html

For more information about Oramed Pharmaceuticals, please visit http//www.oramed.com

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via
'/>"/>

SOURCE Oramed Pharmaceticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
2. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
3. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
4. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
5. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
6. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
7. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
8. Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD
9. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
10. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
11. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., SARASOTA, Fla., Nov. 6 /PRNewswire-FirstCall/ ...nounced that it has signed a definitive agreement ...roprietary medical devices. The Verathon Board of...osing is subject to customary regulatory approvals...roval. The parties expect the closing to be compl...
(Date:11/6/2009)..., PRINCETON, N.J., Nov. 6 /PRNewswire-FirstCall/...DSCI), a provider of advanced wound care products,... results before market on Monday, November 16, 200...me day to discuss the results at 11:00 am EST. Int...ic) or (857) 350-1684 (international), with passco...
(Date:11/6/2009)..., LEXINGTON, Ky., Nov. 6 /PRNewswire-FirstCall/ ... Board: VHGI) confirmed today that the previously ... related assets to Wound Management Technologies, ...ard of Directors and shareholders of VHGI. ,,...he potential stock dividend, royalty stream and ca...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4CorVel Announces Revenues and Earnings 47873 1CorVel Announces Revenues and Earnings 47873 2CorVel Announces Revenues and Earnings 47873 3CorVel Announces Revenues and Earnings 47873 4CorVel Announces Revenues and Earnings 47873 5CorVel Announces Revenues and Earnings 47873 6Leading Sperm Bank Expands Fertility Preservation Services to the Big Apple 47872 1Leading Sperm Bank Expands Fertility Preservation Services to the Big Apple 47872 2DC Government Renews Certified Business Enterprise Classification to Language Interpretation and Translation Firm 47870 1DC Government Renews Certified Business Enterprise Classification to Language Interpretation and Translation Firm 47870 2DC Government Renews Certified Business Enterprise Classification to Language Interpretation and Translation Firm 47870 3
...gs of amylin/leptin synergy and translational Phas... Proceedings of the National Academy of S...O, May 5 Amylin Pharmaceuticals, Inc.,(Nasdaq: A... clinical study,evaluating various dosing combinat...one amylin, and recombinant human leptin (r-metHuL...
...d Improvement in Symptoms Both in the Short and Lo...INGTON, Del., May 5 AstraZeneca (NYSE:,AZN) today...iapine,fumarate) Extended-Release Tablets for the ...eneralized anxiety disorder (GAD) in adult patient...ay at the 161st Annual,Meeting of the American Psy...
Other Medicine Technology:Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity 2Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity 3Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity 4Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity 5New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 2New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 3New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 4New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 5New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 6New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 7New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 8New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 9New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 10New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 11New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 12New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 13New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 14
(Date:11/7/2009)..., HOUSTON, Nov. 7 ...sented Lisa James, Director of Health at the Famil...Distinguished Service today at its semi-annual pol...d Service is the highest honor the AMA House of De... http://www.newscom.com/cgi-bin/prnh/20081209/A...
(Date:11/7/2009)..., HOUSTON, Nov. 7 Calling thi...ociation (AMA), the AMA President J. James Rohack,... physicians from all state and medical specialty s...olicy-making meeting, where health system reform w...com.com/cgi-bin/prnh/20081209/AMALOGO ) ,, "O...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ ...nearing, antichoice extremists are holding the ent...nda. They are demanding that the bill go far beyon... been incorporated into the original bill. In an ...d on early Saturday afternoon, antichoice Democrat...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ ...e House of Representatives to vote for the Stupak-..., "The Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-L... federal law on abortion funding and conscience pr...a Act (H.R. 3962)," they said. ,, The letter wa...
(Date:11/7/2009)... WASHINGTON, Nov. 7 Americans United for Life Act...f the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lip...y federal money from going to abortion in health c...President and CEO Dr. Charmaine Yoest said, "Ameri...Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-...
Breaking Medicine News(10 mins):Health News:AMA Honors Family Violence Prevention Expert 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2
...and Men From 46 States and 7 ...,900 participants in this,weekend,s fifth annual A...illion to advance access to care and finding a cur... grants, with millions,more slated to be awarded t...
...OCS, Inc. and,Press Ganey Associates, Inc. today a...eby the companies have combined their best-of-bree...of products for the home,health care industry. The...ient outcomes and financial performance. The first...
...udy finds , SUNDAY, Oct. 7 (HealthDay News) -- Men...fall have a better chance of survival than those d...Norwegian men suggests. , "Summer and autumn month...at this possibility should be studied further," st...
...,transcript of a radio address by President Bush t... important commitment of the Federal government is...health care. Most of these children are,covered by...struggling, we have the State Children,s Health In...
...d to MRI exposure, scientists say , FRIDAY, Oct. 5...a newly identified disease called nephrogenic syst..., U.S. researchers report. , The researchers also ... condition characterized by a thickening and harde...
...vascular disease , , FRIDAY, Oct. 5 (Healt...re having problems achieving or sustaining erectio...tile dysfunction, or impotence, affects more than ...of research ties erectile dysfunction to vascular ...
Other Medicine News:Health News:Fifth Annual Avon Walk for Breast Cancer New York Raises $10.2 Million 2Health News:Fifth Annual Avon Walk for Breast Cancer New York Raises $10.2 Million 3Health News:OCS and Press Ganey Partner to Create Joint Analysis of Outcomes and Satisfaction 2Health News:Prostate Cancer Survival Varies by Season 2Health News:Radio Address by President Bush to the Nation 2Health News:New Kidney Disease Can Be Fatal 2Health News:Erectile Dysfunction: A Harbinger of Heart Trouble 2Health News:Erectile Dysfunction: A Harbinger of Heart Trouble 3
... the functional management of grade I, II, and III...ed aircell, the brace provides focused, pneumatic ...upporting the arm and shoulder. A detachable sling...al arm support and helps to unload the waist strap...
Humeral Stabilizing System (HSS)
Humerus Fracture Brace
Functional Arm Brace
Medicine Products: